Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 5 Gastrointestinal 3 CNS 3 Thoracic 2 Lymphoid 2 Sarcoma 1 Other hematologic neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Sarcoma 3 Soft Tissue Neoplasms 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Oligodendroglioma 1 Neoplasms 1 Lymphoma 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 17 pembrolizumab 12 Doxorubicin 10 fludarabine 7 Irinotecan 7 Blood Specimen Collection 7 Temozolomide 6 Gemcitabine 6 Etoposide 6 Radiotherapy 5 Ifosfamide 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 tecogalan 4 cemiplimab 4 Vincristine 4 Trabectedin 4 Paclitaxel 4 Nivolumab 4 Filgrastim 4 Drug Therapy 4 Dexamethasone 4 Bevacizumab 4 pazopanib 3 olaparib 3 nilotinib 3 dostarlimab 3 aflibercept 3 Therapeutics 3 Taxes 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Magnetic Resonance Imaging × Sarcoma × Clear all

NCT04394052 2020-07-21

TUMOSTEO II

Central Hospital, Nancy, France

Bone Neoplasms, Neoplasms, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡